Rising Drug Prices: Impact of biosimilars

The entire pharmacy industry is affected by rising drug price prices, and for many those effects are negative. The reasons behind rising drug costs are multiple and complex. This white paper discusses policy issues, success factors and the potential impact of biosimilars on drug prices and healthcare.

While there is no immediate or simple solution for managing rising drug prices, truly current and accurate drug price data ensures that pricing decisions are made with accurate information, reimbursements are fair and balanced, and pricing analysis and reporting is both strong and vigilant.

About Clinical Solutions

Elsevier empowers healthcare providers and educates patients, driving the delivery of high quality, economically sound care through world-class clinical content integrated within clinical workflow and EHR systems.

Learn more